Alzheimer s disease is a leading cause of disability and morbidity in the United States. According to the Alzheimer s Association, 580,000 Floridians aged 65 and older are living with Alzheimer s. Timely diagnosis and treatment can be challenging, but there are clinical tools, biomarkers, and strategies to support accuracy and best practices. This webinar will highlight the necessary elements for accurate diagnosis and provide the latest clinical evidence on available and emerging therapies. At the end of the presentation, learners will be able to: Describe the key necessary diagnostic clinical and biomarkers required for the accurate diagnosis of Alzheimer’s disease Recognize recent FDA-approved disease modifying therapies Discuss the therapies currently being researched for Alzheimer s disease
- Provider:Florida Medical Association
- Activity Link: https://flmedical.inreachce.com/Details/Information/234a835f-4aec-49e2-9932-9657f95fbf72
- Start Date: 2024-06-26 05:00:00
- End Date: 2024-06-26 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Limited